Loading...
InflaRx N.V.

InflaRx N.V. (IFRX)

2.69
-0.02 (-0.92%)

About


Niels Riedemann
Healthcare
Biotechnology
Nasdaq Global Select

InflaRx NV is a biopharmaceutical company. It discovers and develops potent and specific inhibitors of the complement activation factor known as C5a.